These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 22281156)

  • 41. Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis.
    Garnier T; Mäntylä A; Järvinen T; Lawrence MJ; Brown MB; Croft SL
    J Pharm Pharmacol; 2007 Jan; 59(1):41-9. PubMed ID: 17227619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
    Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
    Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
    González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
    Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.
    Kansal S; Tandon R; Dwivedi P; Misra P; Verma PR; Dube A; Mishra PR
    J Antimicrob Chemother; 2012 Nov; 67(11):2650-60. PubMed ID: 22872448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Miltefosine-Lopinavir Combination Therapy Against
    Rebello KM; Andrade-Neto VV; Gomes CRB; de Souza MVN; Branquinha MH; Santos ALS; Torres-Santos EC; d'Avila-Levy CM
    Front Cell Infect Microbiol; 2019; 9():229. PubMed ID: 31316919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis.
    Cauchetier E; Paul M; Rivollet D; Fessi H; Astier A; Deniau M
    Int J Parasitol; 2000 May; 30(6):777-83. PubMed ID: 10856513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
    Corral MJ; Serrano DR; Moreno I; Torrado JJ; Domínguez M; Alunda JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3268-74. PubMed ID: 25096077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
    Cunha-Júnior EF; Andrade-Neto VV; Lima ML; da Costa-Silva TA; Galisteo Junior AJ; Abengózar MA; Barbas C; Rivas L; Almeida-Amaral EE; Tempone AG; Torres-Santos EC
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005281. PubMed ID: 28045892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections.
    Dhorm Pimentel de Moraes AR; Tavares GD; Soares Rocha FJ; de Paula E; Giorgio S
    Exp Parasitol; 2018 Apr; 187():12-21. PubMed ID: 29518448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental treatment with sodium stibogluconate of hamsters infected with Leishmania (Leishmania) chagasi and Leishmania (Leishmania) amazonensis.
    de Figueiredo EM; Costa e Silva J; Brazil RP
    Rev Soc Bras Med Trop; 1999; 32(2):191-3. PubMed ID: 10228371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives.
    Germonprez N; Maes L; Van Puyvelde L; Van Tri M; Tuan DA; De Kimpe N
    J Med Chem; 2005 Jan; 48(1):32-7. PubMed ID: 15633999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
    Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
    Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
    Kaur J; Sundar S; Singh N
    J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of the Anti-Leishmania (Leishmania) infantum Activity of Some Natural Sesquiterpene Lactones.
    Wulsten IF; Costa-Silva TA; Mesquita JT; Lima ML; Galuppo MK; Taniwaki NN; Borborema SET; Da Costa FB; Schmidt TJ; Tempone AG
    Molecules; 2017 Apr; 22(5):. PubMed ID: 28441357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of linalool and eugenol on the survival of Leishmania (L.) infantum chagasi within macrophages.
    Dutra FL; Oliveira MM; Santos RS; Silva WS; Alviano DS; Vieira DP; Lopes AH
    Acta Trop; 2016 Dec; 164():69-76. PubMed ID: 27591136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial peptides isolated from Phyllomedusa nordestina (Amphibia) alter the permeability of plasma membrane of Leishmania and Trypanosoma cruzi.
    Pinto EG; Pimenta DC; Antoniazzi MM; Jared C; Tempone AG
    Exp Parasitol; 2013 Dec; 135(4):655-60. PubMed ID: 24113627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae).
    Grecco Sdos S; Reimão JQ; Tempone AG; Sartorelli P; Cunha RL; Romoff P; Ferreira MJ; Fávero OA; Lago JH
    Exp Parasitol; 2012 Feb; 130(2):141-5. PubMed ID: 22143090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.